Peddock Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.73M | Sell |
7,579
-42
| -0.6% | -$22.8K | 0.82% | 31 |
|
|
2025
Q4 | $4.42M | Buy |
7,621
+204
| +3% | +$115K | 0.93% | 24 |
|
|
2025
Q3 | $3.6M | Buy |
7,417
+15
| +0.2% | +$6.98K | 0.78% | 31 |
|
|
2025
Q2 | $3M | Buy |
7,402
+12
| +0.2% | +$5.02K | 0.69% | 38 |
|
|
2025
Q1 | $3.68M | Sell |
7,390
-293
| -4% | -$159K | 0.93% | 22 |
|
|
2024
Q4 | $4M | Sell |
7,683
-151
| -2% | -$83K | 0.96% | 22 |
|
|
2024
Q3 | $4.85M | Buy |
7,834
+38
| +0.5% | +$22.5K | 1.17% | 17 |
|
|
2024
Q2 | $4.31M | Sell |
7,796
-663
| -8% | -$380K | 1.11% | 20 |
|
|
2024
Q1 | $4.92M | Buy |
8,459
+124
| +1% | +$69.6K | 1.29% | 18 |
|
|
2023
Q4 | $4.42M | Buy |
8,335
+38
| +0.5% | +$18.4K | 1.35% | 17 |
|
|
2023
Q3 | $4.2M | Buy |
8,297
+557
| +7% | +$297K | 1.4% | 16 |
|
|
2023
Q2 | $4.04M | Buy |
7,740
+64
| +0.8% | +$34.5K | 1.33% | 17 |
|
|
2023
Q1 | $4.42M | Buy |
7,676
+91
| +1% | +$51.3K | 1.54% | 13 |
|
|
2022
Q4 | $4.18M | Buy |
7,585
+22
| +0.3% | +$11.7K | 1.62% | 13 |
|
|
2022
Q3 | $3.84M | Sell |
7,563
-176
| -2% | -$98.5K | 1.58% | 14 |
|
|
2022
Q2 | $4.2M | Sell |
7,739
-61
| -0.8% | -$33.6K | 1.64% | 11 |
|
|
2022
Q1 | $4.61M | Buy |
7,800
+86
| +1% | +$49.4K | 1.49% | 13 |
|
|
2021
Q4 | $5.15M | Sell |
7,714
-125
| -2% | -$78K | 1.7% | 11 |
|
|
2021
Q3 | $4.48M | Sell |
7,839
-182
| -2% | -$99.9K | 1.6% | 11 |
|
|
2021
Q2 | $4.33M | Buy |
8,021
+50
| +0.6% | +$23.6K | 1.51% | 12 |
|
|
2021
Q1 | $3.64M | Buy |
7,971
+93
| +1% | +$44.4K | 1.39% | 14 |
|
|
2020
Q4 | $3.67M | Sell |
7,878
-53
| -0.7% | -$24.9K | 1.91% | 9 |
|
|
2020
Q3 | $3.5M | Sell |
7,931
-154
| -2% | -$63.6K | 2.15% | 8 |
|
|
2020
Q2 | $2.93M | Sell |
8,085
-152
| -2% | -$50.9K | 1.85% | 10 |
|
|
2020
Q1 | $2.34M | Sell |
8,237
-23
| -0.3% | -$7.25K | 1.75% | 11 |
|
|
2019
Q4 | $2.68M | Sell |
8,260
-199
| -2% | -$60.3K | 1.37% | 13 |
|
|
2019
Q3 | $2.46M | Sell |
8,459
-459
| -5% | -$131K | 1.37% | 13 |
|
|
2019
Q2 | $2.62M | Hold |
8,918
| – | – | 1.39% | 12 |
|
|
2019
Q1 | $2.44M | Buy |
8,918
+189
| +2% | +$47K | 1.32% | 9 |
|
|
2018
Q4 | $1.95M | Sell |
8,729
-189
| -2% | -$44.3K | 1.16% | 12 |
|
|
2018
Q3 | $2.18M | Buy |
8,918
+85
| +1% | +$19.6K | 1.05% | 13 |
|
|
2018
Q2 | $1.83M | Sell |
8,833
-5
| -0.1% | -$1.06K | 0.92% | 19 |
|
|
2018
Q1 | $1.82M | Sell |
8,838
-54
| -0.6% | -$11.3K | 0.96% | 15 |
|
|
2017
Q4 | $1.69M | Sell |
8,892
-7
| -0.1% | -$1.34K | 0.85% | 19 |
|
|
2017
Q3 | $1.68M | Buy |
8,899
+63
| +0.7% | +$11.4K | 0.86% | 16 |
|
|
2017
Q2 | $1.54M | Buy |
8,836
+1,227
| +16% | +$206K | 0.82% | 19 |
|
|
2017
Q1 | $1.17M | Buy |
7,609
+287
| +4% | +$43.9K | 0.68% | 26 |
|
|
2016
Q4 | $1.03M | Buy |
7,322
+726
| +11% | +$107K | 0.61% | 29 |
|
|
2016
Q3 | $1.05M | Hold |
6,596
| – | – | 0.64% | 26 |
|
|
2016
Q2 | $975K | Buy |
6,596
+53
| +0.8% | +$7.82K | 0.62% | 26 |
|
|
2016
Q1 | $926K | Buy |
6,543
+28
| +0.4% | +$3.75K | 0.7% | 28 |
|
|
2015
Q4 | $924K | Buy |
6,515
+295
| +5% | +$39.3K | 0.71% | 30 |
|
|
2015
Q3 | $761K | Buy |
6,220
+8
| +0.1% | +$1.04K | 0.69% | 32 |
|
|
2015
Q2 | $806K | Buy |
6,212
+174
| +3% | +$22.7K | 0.66% | 36 |
|
|
2015
Q1 | $811K | Buy |
6,038
+166
| +3% | +$21.4K | 0.67% | 34 |
|
|
2014
Q4 | $736K | Buy |
5,872
+202
| +4% | +$24.6K | 0.6% | 42 |
|
|
2014
Q3 | $690K | Hold |
5,670
| – | – | 0.56% | 42 |
|
|
2014
Q2 | $669K | Buy |
5,670
+110
| +2% | +$12.9K | 0.5% | 42 |
|
|
2014
Q1 | $669K | Buy |
5,560
+249
| +5% | +$29.6K | 0.52% | 41 |
|
|
2013
Q4 | $591K | Buy |
+5,311
| New | +$528K | 0.46% | 42 |
|
Other funds holding TMO
VCM
Peddock Capital Advisors's TMO Position: Q1 2026 in Review
Peddock Capital Advisors reduced its Thermo Fisher Scientific (TMO) stake by 0.55% in Q1 2026, selling an estimated $22.8K and leaving 7,579 shares worth $3.73M. The position accounts for 0.82% of the portfolio, ranked #31.
Peddock Capital Advisors first reported a position in TMO in Q4 2013 and has held it in 50 quarters since. The position peaked at $5.15M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Peddock Capital Advisors held 7,579 shares of Thermo Fisher Scientific worth $3.73M as of Q1 2026.
- Peddock Capital Advisors sold 42 Thermo Fisher Scientific shares in Q1 2026, an estimated $22.8K.
- Thermo Fisher Scientific made up 0.82% of Peddock Capital Advisors's portfolio in Q1 2026, its #31 holding.
- Peddock Capital Advisors first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 50 quarters since.
- Peddock Capital Advisors's Thermo Fisher Scientific position peaked at $5.15M in Q4 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Peddock Capital Advisors's 13F filing for Q1 2026, filed 15 Apr 2026.